Mar 9, 2023 by James Halley3 Top Pot Stocks to Buy Right NowFocus on the long-term possibilities with companies that are already financially strong.
Mar 9, 2023 by James HalleyMissed Out on Vertex? My Best Gene-Editing Stock to Buy and HoldGet in on CRISPR Therapeutics before it gets expensive.
Mar 8, 2023 by James HalleyWhy Treace Medical Concepts' Shares Rose WednesdayThe company's Lapiplasty surgery kits are driving increased revenue.
Mar 8, 2023 by James HalleyWhy LifeStance Health's Shares Jumped WednesdayThe company saw revenue climb by 29% in 2022.
Mar 8, 2023 by James HalleyBeat the Dow Jones With This Unstoppable Dividend StockMerck had a strong year and has the portfolio and pipeline to increase its dividend.
Mar 7, 2023 by James HalleyWhy Shares of Ambrx Biopharma Fell TuesdayAfter getting a bump on Monday for its switch to the Nasdaq Stock Market, there was a bit of a correction.
Mar 7, 2023 by James Halley2 Reasons to Buy Green Thumb and 1 Reason Not toGreen Thumb will likely be one of the cannabis survivors.
Mar 7, 2023 by James HalleyBetter Cannabis Stock Buy: Cresco Labs or Innovative Industrial Properties?Both stocks have fallen a lot in a year -- is now the time to buy either?
Mar 6, 2023 by James HalleyWhy Shares of Anavex Life Sciences Rose 12.4% in FebruaryThe company's first-quarter earnings report detailed positive news regarding its pipeline.
Mar 5, 2023 by James HalleyBetter Generics Pharmaceutical Stock: Teva or Viatris?Both have plans to return to growth.
Mar 4, 2023 by James Halley3 Things About CRISPR Therapeutics That Smart Investors KnowInstitutional investors might be on to something.
Mar 3, 2023 by James HalleyWhy Shares of Progyny Rose 18.4% This WeekThe company reported record revenue at the beginning of the week.
Mar 2, 2023 by James HalleyWhy Sarepta Therapeutics' Shares Rose 23.4% This WeekThe company's latest Duchenne muscular dystrophy gene therapy may have an accelerated approval.
Mar 2, 2023 by James HalleyWhy Shares of BioVie Jumped 51.7% in FebruaryThe company is forging ahead with a phase 3 trial for its lead therapy.
Mar 1, 2023 by James HalleyWhy Alignment Healthcare's Shares Dropped TodayThe Medicare Advantage insurer reported a loss in its fourth-quarter earnings.
Mar 1, 2023 by James HalleyWhy Shares of Amphastar Pharmaceuticals Rose TodayThe company reported a record revenue year and increased EPS.
Mar 1, 2023 by James HalleyWhy Shares of Schrödinger Were Up TodayThe company delivered a nice earnings surprise.
Mar 1, 2023 by James HalleyIs Medtronic Still a Great Dividend Stock?Innovation and consistent dividend increases attract investors.
Mar 1, 2023 by James HalleyGet a Dividend Every Month With These 3 Healthcare StocksWith a little planning, you can receive a dependable dividend payout every month.
Feb 28, 2023 by James HalleyWhy Compugen Shares Are Up TodayThe company released its fourth-quarter and full-year results after the bell Monday.
